Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
MCM Vaccines B.V.
With
Merck Sharp & Dohme LLC
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy infants able to attend all study visits
Parent(s)/legal representative able to read, understand, and complete study questionnaires
You may not be if
History of congenital or acquired immunodeficiency
Received or is expected to receive immunosuppressive agents or systemic immunomodulatory steroids
History of leukemia, lymphoma, malignant melanoma, or myeloproliferative disorder
Hypersensitivity to any of the vaccine components or history of a life-threatening reaction to a vaccine containing the same substances as the study vaccines or concomitant study vaccines
Has any chronic illness that could interfere with study conduct or completion
Received any immune globulin, blood, or blood-derived products since birth
Received a dose of hepatitis B vaccine prior to the study
Vaccinated with any acellular pertussis or whole cell pertussis based combination vaccines, Haemophilus influenzae type b conjugate, poliovirus, pneumococcal conjugate or pneumococcal polysaccharide, rotavirus, measles, mumps, rubella, or varicella vaccines, or any combination thereof
Fever within 24 hours prior to enrollment
Received any non-study vaccine within 30 days prior to enrollment, except for inactivated influenza vaccine, which is permitted 14 days or more prior to enrollment
Has a coagulation disorder
Has developmental delay or neurological disorder
Participant or his/her mother has a medical history of hepatitis B surface antigen (HBsAg) seropositivity
History of measles, mumps, rubella, varicella, Haemophilus influenzae type B, hepatitis B, diphtheria, tetanus, pertussis, rotavirus, invasive pneumococcal, or poliomyelitis infection
